BGB-3111
BGB-3111-302
Phase 3 small_molecule completed
Quick answer
BGB-3111 for Waldenström's Macroglobulinemia is a Phase 3 program (small_molecule) at BeiGene with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeiGene
- Indication
- Waldenström's Macroglobulinemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed